Johnson Wendy S. insider trades
Johnson Wendy S. has filed 5 Form 4s with the SEC that we hold, for Exagen INC. (XGN) (Director) and OnKure Therapeutics, Inc. (RPHM) (Chief Development Officer). Across all of them we count 1 purchase worth $14.0K and 1 sale worth $949.8K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 111,736 shares of OnKure Therapeutics, Inc. worth $949.8K, dated 2021-07-14. The first filing on our record is dated 2021-07-09 and the latest 2023-06-13.
Exagen INC. (XGN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-03 | P, purchase reported on Form 4 | 1,000 | $14.0K | 2021-09-07 |
OnKure Therapeutics, Inc. (RPHM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-14 | S, sale reported on Form 4 | 111,736 | $949.8K | 2021-07-15 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1652822) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms